Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in bone and mineral, intractable hematologic, hematology oncology, and rare diseases. The company is headquartered in Princeton, NJ with offices in California, Massachusetts, and Ontario, and is committed to making people smile by delivering breakthroughs.